Sign in
4

Changes in Ownership

RHYTHM PHARMACEUTICALS, INC. Filed Acc 0001104659-23-022114

Chief Technical Officer sold 554 shares at $26.87 ($14,886)

  • Chief Technical Officer acquired 1,563 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
Shulman Joseph Chief Technical Officer 2023-02-11 Option exercise +1,563 4,295 D
Shulman Joseph Chief Technical Officer 2023-02-14 Sale −554 $26.87 $14,886 3,741 D
Derivatives
Shulman Joseph Chief Technical Officer 2023-02-11 Option exercise · Restricted Stock Units −1,563 3,124 D
Open-market sales · 554 sh · avg $26.87 · $14,886
Loading xslF345X03/tm236871-10_4seq1.xml…